Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Stomach Neoplasms 2 Small Cell Lung Carcinoma 2 Neoplasm Metastasis 1 DLBCL 1 Carcinoma, Renal Cell 1

Interventions

Sunitinib 27 Nivolumab 26 pembrolizumab 23 Sorafenib 17 Everolimus 14 Cyclophosphamide 13 Interleukin-2 10 Bevacizumab 10 Radiosurgery 9 spartalizumab 8 pazopanib 7 atezolizumab 7 Ipilimumab 7 Axitinib 7 fludarabine 6 aldesleukin 6 cabozantinib 5 Radiotherapy 5 Magnetic Resonance Spectroscopy 5 Immunohistochemistry 5 Gemcitabine 5 peginterferon alfa-2b 4 avelumab 4 Nephrectomy 4 Irinotecan 4 Introns 4 Gene Expression Profiling 4 Capecitabine 4 lenvatinib 3 fludarabine phosphate 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Terminated × Carcinoma, Renal Cell × vistusertib × Clear all

NCT01793636 2014-06-24

ZEBRA

Queen Mary University of London

Phase 2 Terminated

Carcinoma, Renal Cell

Data powered by HemOnc (CC BY 4.0) Colophon ⚡